On April 4, 2022, RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cell and exosome bioprocessing systems for cell and gene therapy product developers, announced that the company has been joined by Robert Preti, PhD, as a member of its board of directors. Dr. Preti (photo) brings an extensive history of innovation in the cell and gene therapy industry, experience developing and managing global business operations, and leadership honed through driving growth in several regenerative medicine organizations.
Login Or Register To Read Full Story